Investor Relations

SEC Filings

Document Details

Form
Filing Date
Apr 13, 2023
Document Date
Apr 03, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.